Literature DB >> 3689735

Natural history of retinopathy of prematurity.

W E Schulenburg1, A Prendiville, R Ohri.   

Abstract

Sixty-nine infants at risk of developing retinopathy of prematurity (ROP) were entered into a prospective study to assess the incidence and natural history of the disease. Seventeen infants developed ROP, and in six eyes the disease progressed to stage IV ROP. The natural regression of a pupillary membrane and physiological vitreous haze was not influenced by the onset of ROP. Progression from stage I to stage III was rapid and the rate was influenced by the zone affected. Congestion and tortuosity of vessels in the posterior pole always signified stage III ROP. Progression from stage III to stage IV ROP was slower; it was characterised by the development of vitreoretinopathy, signified by the sudden onset of a vitreous haze. Iris congestion associated with poor mydriasis may be a grave sign indicating imminent retinal detachment. Cicatricial ROP can be divided into retinal and vitreoretinal cicatricial disease directly related to the stage of active disease reached. ROP is characterised by its self limiting nature, but the stage at which it becomes inactive varies and will influence the final outcome.

Entities:  

Mesh:

Year:  1987        PMID: 3689735      PMCID: PMC1041321          DOI: 10.1136/bjo.71.11.837

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Acute proliferative retrolental fibroplasia: evolution of the lesion.

Authors:  J T Flynn
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975

2.  Cryotherapy for retinopathy of prematurity. A personal retrospective.

Authors:  D K Mousel
Journal:  Ophthalmology       Date:  1985-03       Impact factor: 12.079

3.  Vascular tufts in retrolental fibroplasia.

Authors:  I Garoon; G Epstein; M Segall; M F Rabb; F LaFranco; T C Quirk
Journal:  Ophthalmology       Date:  1980-11       Impact factor: 12.079

4.  Retinopathy of prematurity: incidence and risk factors.

Authors:  M Shohat; S H Reisner; R Krikler; I Nissenkorn; Y Yassur; I Ben-Sira
Journal:  Pediatrics       Date:  1983-08       Impact factor: 7.124

5.  Retrolental fibroplasia: I. Clinical observations.

Authors:  J T Flynn; G E O'Grady; J Herrera; B J Kushner; S Cantolino; W Milam
Journal:  Arch Ophthalmol       Date:  1977-02

6.  Acute retrolental fibroplasia. II. Treatment by cryosurgery.

Authors:  J D Kingham
Journal:  Arch Ophthalmol       Date:  1978-11

7.  Retinopathy of prematurity: incidence and treatment.

Authors:  S H Reisner; J Amir; M Shohat; R Krikler; I Nissenkorn; I Ben-Sira
Journal:  Arch Dis Child       Date:  1985-08       Impact factor: 3.791

8.  Closed vitrectomy for severe retrolental fibroplasia in the infant.

Authors:  R Machemer
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

9.  Current therapy of retrolental fibroplasia. Retinopathy of prematurity.

Authors:  A Patz
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

10.  Treatment of acute retrolental fibroplasia by cryopexy.

Authors:  I Ben-Sira; I Nissenkorn; E Grunwald; Y Yassur
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

  10 in total
  10 in total

Review 1.  Screening for retinopathy of prematurity.

Authors:  A R Fielder; M I Levene
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

2.  Spontaneous regression of retinopathy of prematurity: incidence and predictive factors.

Authors:  Rui-Hong Ju; Jia-Qing Zhang; Xiao-Yun Ke; Xiao-He Lu; Li-Fang Liang; Wu-Jun Wang
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

3.  Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.

Authors:  I A Pearce; F C Pennie; L M Gannon; A M Weindling; D I Clark
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

4.  Retinopathy of prematurity: late complications in the baby boomer generation (1946-1964).

Authors:  Bradley T Smith; William S Tasman
Journal:  Trans Am Ophthalmol Soc       Date:  2005

5.  Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

Authors:  David K Coats
Journal:  Trans Am Ophthalmol Soc       Date:  2005

6.  A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden.

Authors:  G Holmström; M el Azazi; L Jacobson; G Lennerstrand
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

7.  The progression of retinopathy of prematurity and fluctuation in blood gas tension.

Authors:  Y Saito; T Omoto; Y Cho; Y Hatsukawa; M Fujimura; T Takeuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-03       Impact factor: 3.117

8.  Late onset vitreoretinal complications of regressed retinopathy of prematurity.

Authors:  A Tufail; A J Singh; R J Haynes; C R Dodd; D McLeod; D G Charteris
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

9.  LONGITUDINAL CHANGES IN THE OPTIC NERVE HEAD AND RETINA OVER TIME IN VERY YOUNG CHILDREN WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.

Authors:  Jonghyun Lee; Mays A El-Dairi; Du Tran-Viet; Shwetha Mangalesh; Alexandria Dandridge; Kim Jiramongkolchai; Christian Viehland; Cynthia A Toth
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

10.  Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis.

Authors:  Tomoaki Higashiyama; Sanae Muraki; Masahito Ohji
Journal:  Case Rep Ophthalmol       Date:  2017-03-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.